CEP290 Antikörper (C-Term)
-
- Target Alle CEP290 Antikörper anzeigen
- CEP290 (Centrosomal Protein 290kDa (CEP290))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CEP290 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB), Immunohistochemistry (IHC)
- Spezifität
- Reacts with mouse 290 kD Cep290 protein. May cross reacts with proteins from rat and human due to sequences homology.
- Aufreinigung
- Protein A purified
- Immunogen
-
Synthetic peptide derived from C-ter domain of mouse Cep290.
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product CEP290 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Target Species of Antibody: Mouse
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- 100 mM Tris-glycine, 2 % sucrose
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at 4°C. For extended periods store in aliquots at -20°C.
-
- Target
- CEP290 (Centrosomal Protein 290kDa (CEP290))
- Andere Bezeichnung
- CEP290 (CEP290 Produkte)
- Hintergrund
-
Name/Gene ID: CEP290
Synonyms: CEP290, 3H11Ag, Cancer/testis antigen 87, Centrosomal protein of 290 kDa, CTCL tumor antigen se2-2, CT87, Centrosomal protein 290 kDa, JBTS5, JBTS6, Meckel syndrome, type 4, Nephrocytsin-6, NPHP6, POC3, KIAA0373, Rd16, MKS4, SLSN6, BBS14, Nephrocystin-6, Prostate cancer antigen T21, Tumor antigen se2-2 - Gen-ID
- 80184
- UniProt
- O15078
- Pathways
- cAMP Metabolic Process, M Phase
-